Summary
- Current Price
- As of today, IQV price is $249.28, up +3.85% on
- Current Price All-Time High
- IQV price is currently -12.72% below its historical high of $285.61 set on
- Market Cap
- IQV current market cap is $41B, up +25.48% over the past 365 days
- PE Ratio
- IQV current PE ratio is 30.92
- Revenue
- IQV current annual revenue is $16.30B, up +5.84% year-over-year
- Next Earnings
- The next earnings release for IQV is on
Profile
| Metric | Value |
|---|---|
| Full Name | IQVIA Holdings Inc. |
| Ticker | NYSE: IQV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | iqvia.com |
| Employees | 90,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $249.28 | |
| Price, 1D Change | +3.85% | |
| Market Cap | $41B | |
| - | ||
| PE Ratio | 30.92 | |
| Beta | 0.83 | |
| Revenue | $16.30B | |
| Revenue, 1Y Change | +5.84% | |
| EPS | $7.84 | |
| EPS, 1Y Change | +4.70% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | Q | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $7.84 | |
| EPS Estimate | $12.96 | N/A |
| EPS Est. Change | +65.37% | N/A |
| Revenue | $16.30B | |
| Revenue Estimate | $17.41B | N/A |
| Revenue Est. Change | +6.81% | N/A |
| Current Price | $249.28 | |
| Price Target | $278.00 | - |
| Price Tgt. Change | +11.52% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.12 | $7.49 | -32.65% | |
| $11.92 | $7.84 | -34.25% | |
| $12.96 | N/A | +65.37% | |
| $14.44 | N/A | +84.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.38B | $15.41B | +0.17% | |
| $16.18B | $16.30B | +0.74% | |
| $17.41B | N/A | +6.81% | |
| $18.47B | N/A | +13.28% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +29.60% | |
| Price, 3Y | +16.50% | |
| Market Cap, 1Y | +25.48% | |
| Market Cap, 3Y | +4.73% | |
| Revenue, 1Y | +5.84% | |
| Revenue, 3Y | +13.07% | |
| EPS, 1Y | +4.70% | |
| EPS, 3Y | +36.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $249.28 | |
| SMA 200 | $199.10 | |
| SMA 50 | $210.01 | |
| EMA 200 | $197.20 | |
| EMA 50 | $215.89 | |
| MACD | $9.75 | |
| Beta | 0.83 | |
| ATR | $8.13 | |
| 14-Day RSI | 67.64 | |
| 10-Day Volatility | 30.29% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $16.30B | |
| EPS | $7.84 | |
| Gross Profit | $4.29B | |
| Gross Margin | 26.28% | |
| Operating Income | $2.29B | |
| Operating Margin | 14.02% | |
| Net Income | $1.36B | |
| Net Margin | 8.33% | |
| EBITDA | $3.43B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.50 | |
| 0.75 | ||
| 0.75 | ||
| - | ||
| 7 | ||
| 2.12 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 30.92 | |
| 2.42 | ||
| 6.65 | ||
| 15.57 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $6.50B | |
| $2.14B | ||
| $29.94B | ||
| $6.25B | ||
| $23.31B | ||
| $8.34B | ||
| Total Debt | $16.26B | |
| $1.94B | ||
| $780.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $14.95B | ||
| $2.00B | ||
| $12.02B | ||
| $0.00 | ||
| $1.14B | ||
| $0.00 | ||
| $252.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $2.65B | ||
| -$2.31B | ||
| -$150.00M | ||
| Capex | $603.00M | |
| $2.05B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | → | |
| Stifel | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| BMO Capital | → | |
| Baird | → | |
| Mizuho | → | |
| Baird | → | |
| Morgan Stanley | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with IQV
FAQ
- What is the ticker symbol for IQVIA Holdings Inc.?
- The ticker symbol for IQVIA Holdings Inc. is NYSE:IQV
- Does IQVIA Holdings Inc. pay dividends?
- No, IQVIA Holdings Inc. does not pay dividends
- What sector is IQVIA Holdings Inc. in?
- IQVIA Holdings Inc. is in the Healthcare sector
- What industry is IQVIA Holdings Inc. in?
- IQVIA Holdings Inc. is in the Diagnostics & Research industry
- What country is IQVIA Holdings Inc. based in?
- IQVIA Holdings Inc. is headquartered in United States
- When did IQVIA Holdings Inc. go public?
- IQVIA Holdings Inc. initial public offering (IPO) was on May 9, 2013
- Is IQVIA Holdings Inc. in the S&P 500?
- Yes, IQVIA Holdings Inc. is included in the S&P 500 index
- Is IQVIA Holdings Inc. in the NASDAQ 100?
- No, IQVIA Holdings Inc. is not included in the NASDAQ 100 index
- Is IQVIA Holdings Inc. in the Dow Jones?
- No, IQVIA Holdings Inc. is not included in the Dow Jones index
- When was IQVIA Holdings Inc. last earnings report?
- IQVIA Holdings Inc.'s most recent earnings report was on July 28, 2026
- When does IQVIA Holdings Inc. report earnings?
- The next expected earnings date for IQVIA Holdings Inc. is November 3, 2026
Data Sources & References
- IQV Official Website www.iqvia.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000119312525312900/0001193125-25-312900-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
- IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv